Galan P, Favier A, Preziosi P, Bertrais S, Arnault N, Hercberg S
U557 INSERM (UMR INSERM/INRA/CNAM), ISTNA-CNAM, 5, rue du Vertbois, 75003 Paris.
Rev Epidemiol Sante Publique. 2003 Feb;51(1 Pt 2):147-50.
The "SUpplémentation en VItamines et Minéraux AntioXydants" (SU.VI.MAX) study is a randomized double-blind, placebo-controlled, primary-prevention trial designed to test the efficacy of a daily supplementation with antioxidant vitamins and minerals at nutritional doses, in reducing several major health problems in industrialized countries, and especially the main causes of premature death (cancers and cardiovascular diseases). This 8-year cohort study started in 1994 in France; 13,535 eligible subjects (women aged 35 to 60, and men aged 45 to 60) were included in 1994 and will be followed up for 8 years. In this paper are described conditions and practical aspects for the realisation of the biological bank developped on the first sample (1994) and completed in 1996 and 1999. Biological material (buffy coat and plasma samples) are saved and stored at -196 degrees C, -80 degrees C and -20 degrees C for any further tests planned at later date (case-control studies and/or validation of new hypothesis).
“抗氧化维生素和矿物质补充剂”(SU.VI.MAX)研究是一项随机双盲、安慰剂对照的一级预防试验,旨在测试每日补充营养剂量的抗氧化维生素和矿物质,对减少工业化国家的几种主要健康问题,尤其是过早死亡(癌症和心血管疾病)的主要原因的功效。这项为期8年的队列研究于1994年在法国启动;1994年纳入了13535名符合条件的受试者(35至60岁的女性和45至60岁的男性),并将进行8年的随访。本文描述了1994年采集的首批样本并于1996年和1999年完成的生物样本库的建立条件及实际情况。生物材料(血沉棕黄层和血浆样本)保存在-196℃、-80℃和-20℃,以备日后计划进行的任何进一步检测(病例对照研究和/或新假设的验证)。